Miyazawa T, Arita K
Department of Pulmonary Medicine, Hiroshima City Hospital, Japan.
Respirology. 1998 Dec;3(4):229-34. doi: 10.1111/j.1440-1843.1998.tb00127.x.
Various types of outstanding airway stents have been made commercially available. In Japan, a total of 1004 airway stents (Dumon stents (Novatech, Aubagne, France), Gianturco Z stents (Cook Ins, Bloomington, USA), Ultraflex stents (Boston Scientific Corp, Natick, MA, USA), and Dynamic Y stents (Ruesch AG, Kernen, Germany)) were implanted from July 1991 until February 1998. Of all the various stents, the Dumon stent has become the standard worldwide. Also, the Dumon stent has been replacing the Gianturco Z stent as the preferred stent throughout Japan. The Dumon stent was the first stent covered by Japanese National Health Insurance. Therefore, we present our 5-year experience with the Dumon stent at our institution. In our experience, stenting is effective for the immediate and lasting relief of symptoms in patients with severe malignant obstruction of major airways.
各种类型的优质气道支架已投入商业使用。在日本，从1991年7月至1998年2月共植入了1004个气道支架（杜蒙支架（法国奥巴涅的诺瓦泰克公司）、朱安图尔科Z形支架（美国布卢明顿的库克公司）、超柔性支架（美国马萨诸塞州纳蒂克的波士顿科学公司）和动态Y形支架（德国克嫩的吕施公司））。在所有不同的支架中，杜蒙支架已成为全球标准。此外，在日本全国，杜蒙支架已逐渐取代朱安图尔科Z形支架，成为首选支架。杜蒙支架是首个被日本国民健康保险覆盖的支架。因此，我们介绍在我们机构使用杜蒙支架的5年经验。根据我们的经验，对于患有严重主气道恶性梗阻的患者，支架置入术能有效立即且持久地缓解症状。
